HTR4 and Alzheimer disease: Gs-protein-coupled serotonin receptors (5-HTR) 5-HT6, 5-HT4 and 5-HT7 (5-HT4R, 5-HT6R and 5-HT7R, respectively) are of particular interest as molecular targets for AD management.